UNIKUM Therapeutics ApS: Financial statements 2023
CVR: 41192925
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
UNIKUM Therapeutics ApS (CVR 41192925) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,465,410 and a net result of DKK -14,870,759 compared with DKK -7,648,614 the year before. Equity in the 2023 report amounted to DKK -16,283,891. The company had 9 employees in the financial year.
- Gross Profit
- DKK -7,465,410
- Profit/Loss
- DKK -14,870,759
- Equity
- DKK -16,283,891
- Total Assets
- DKK 3,996,302
- Employees
- 9
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -7.5M | -14.9M | -16.3M | 9 |
| 2022 | - | -3.3M | -7.6M | -15.3M | 7 |
| 2021 | - | -2.7M | -5.6M | -7.6M | 5 |
| 2020 | - | -1.1M | -2.1M | -2.1M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 4, 2023, MEDIC ADVICE ApS is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 5%.
As of October 4, 2023, RO Bak Holding ApS is registered as an owner of UNIKUM Therapeutics ApS with an ownership share of 5%.
As of September 30, 2023, Rasmus Otkjær Bak has stepped down as adm. dir. of UNIKUM Therapeutics ApS.
As of August 1, 2023, Margo Rosemary Roberts has joined the board of directors of UNIKUM Therapeutics ApS.
UNIKUM Therapeutics ApS has published its annual report for 2022. Gross profit came to DKK -3,315,358, and the net result was DKK -7,648,614.
As of April 18, 2023, Rasmus Otkjær Bak is registered as adm. dir. of UNIKUM Therapeutics ApS.
As of April 18, 2023, Tommi Petteri Kainu is registered as director of UNIKUM Therapeutics ApS.
As of April 17, 2023, Rasmus Otkjær Bak has stepped down as director of UNIKUM Therapeutics ApS.
As of March 2, 2023, Johannes Heinrich Frühauf has joined the board of directors of UNIKUM Therapeutics ApS.
As of March 2, 2023, Nebojsa Milovic has joined the board of directors of UNIKUM Therapeutics ApS.
About UNIKUM Therapeutics ApS
UNIKUM Therapeutics ApS is a Danish company of the type Anpartsselskab based in Risskov, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Roelsgaard Jakobsen. The board consists of Ulrik Bjerl Nielsen (chair), Martin Roelsgaard Jakobsen and Stefan Wildt. The company's owners include MEDIC ADVICE ApS, MR Jakobsen Holding ApS and BII Holdings A/S. The company has 2 employees (2025). In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.
